Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer
Authors
Keywords
ovarian cancer, metastasis, miR-9, E-cadherin
Journal
Frontiers of Medicine
Volume 11, Issue 2, Pages 214-222
Publisher
Springer Nature
Online
2017-05-04
DOI
10.1007/s11684-017-0518-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells
- (2016) Jingyi Yu et al. Nature Communications
- MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer
- (2014) Jae Moon Gwak et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
- (2013) Chaoyang Sun et al. JNCI-Journal of the National Cancer Institute
- Sensitive detection of melanoma metastasis using circulating microRNA expression profiles
- (2013) Rie Shiiyama et al. MELANOMA RESEARCH
- TGF-β upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1
- (2013) Yinghe Qiu et al. Molecular BioSystems
- MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma
- (2013) Zhao Sun et al. Molecular Oncology
- microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1
- (2013) Liduan Zheng et al. PLoS One
- Prospero Homeobox 1 Promotes Epithelial-Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
- (2012) M.-H. Lu et al. CLINICAL CANCER RESEARCH
- Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis
- (2012) S M Wilting et al. ONCOGENE
- Downregulation of IRS-1 promotes metastasis of head and neck squamous cell carcinoma
- (2012) XUAN LUO et al. ONCOLOGY REPORTS
- miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes
- (2011) Harsh Dweep et al. JOURNAL OF BIOMEDICAL INFORMATICS
- MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility
- (2011) Liang Zhu et al. MEDICAL ONCOLOGY
- Genome-wide profiling at methylated promoters in pancreatic adenocarcinoma
- (2010) Noriyuki Omura et al. CANCER BIOLOGY & THERAPY
- Epithelial–mesenchymal transition in ovarian cancer
- (2009) Daniele Vergara et al. CANCER LETTERS
- Metastamir: The Field of Metastasis-Regulatory microRNA Is Spreading
- (2009) D. R. Hurst et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Ovarian Cancer
- (2008) Kathleen R. Cho et al. Annual Review of Pathology-Mechanisms of Disease
- MiR-92b and miR-9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors
- (2008) Dvora Nass et al. BRAIN PATHOLOGY
- Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells
- (2008) Danhui Weng et al. CANCER LETTERS
- Early Events in the Pathogenesis of Epithelial Ovarian Cancer
- (2008) Charles N. Landen et al. JOURNAL OF CLINICAL ONCOLOGY
- Potential role of miR-9 and miR-223 in recurrent ovarian cancer
- (2008) Alexandros Laios et al. Molecular Cancer
- MicroRNA in Cancer Prognosis
- (2008) Frank J. Slack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic inactivation of microRNA genehsa-mir-9-1in human breast cancer
- (2007) U Lehmann et al. JOURNAL OF PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started